Publications by authors named "Karthik Sheshachala"

Previous diffusion MRI studies have reported mixed findings on white matter microstructure alterations in obsessive-compulsive disorder (OCD), likely due to variation in demographic and clinical characteristics, scanning methods, and underpowered samples. The OCD global study was created across five international sites to overcome these challenges by harmonizing data collection to identify consistent brain signatures of OCD that are reproducible and generalizable. Single-shell diffusion measures (e.

View Article and Find Full Text PDF

Objective: To describe the steps of ensuring measurement fidelity of core clinical measures in a five-country study on brain signatures of obsessive-compulsive disorder (OCD).

Method: We collected data using standardized instruments, which included the Yale-Brown Obsessive-Compulsive Scale (YBOCS), the Dimensional YBOCS (DYBOCS), the Brown Assessment of Beliefs Scale (BABS), the 17-item Hamilton Depression Scale (HAM-D), the Hamilton Anxiety Scale (HAM-A), and the Structured Clinical Interview for DSM-5 (SCID). Steps to ensure measurement fidelity included translating instruments, developing a clinical decision manual, and continuing reliability training with 11-13 transcripts of each instrument by 13 independent evaluators across sites over 4 years.

View Article and Find Full Text PDF

Objectives: We describe the harmonized MRI acquisition and quality assessment of an ongoing global OCD study, with the aim to translate representative, well-powered neuroimaging findings in neuropsychiatric research to worldwide populations.

Methods: We report on T1-weighted structural MRI, resting-state functional MRI, and multi-shell diffusion-weighted imaging of 140 healthy participants (28 per site), two traveling controls, and regular phantom scans.

Results: Human image quality measures (IQMs) and outcome measures showed smaller within-site variation than between-site variation.

View Article and Find Full Text PDF

Objective: Cross-national work on neurocognitive testing has been characterized by inconsistent findings, suggesting the need for improved harmonization. Here, we describe a prospective harmonization approach in an ongoing global collaborative study.

Method: Visuospatial -Back, Tower of London (ToL), Stop Signal task (SST), Risk Aversion (RA), and Intertemporal Choice (ITC) tasks were administered to 221 individuals from Brazil, India, the Netherlands, South Africa, and the USA.

View Article and Find Full Text PDF
Article Synopsis
  • Glutamate is a key chemical in the brain that helps send signals and is important for many brain functions, but it can also contribute to problems like brain injuries and movement issues.
  • It is linked to several mental health disorders, such as epilepsy, Alzheimer's, and OCD (Obsessive-Compulsive Disorder), which is what this article focuses on.
  • The article reviews how glutamate affects OCD, including its symptoms and treatments, and looks at what scientists have learned so far and what they plan to study in the future.
View Article and Find Full Text PDF

Background: Obsessive-compulsive disorder (OCD) has a lifetime prevalence of 2-3% and is a leading cause of global disability. Brain circuit abnormalities in individuals with OCD have been identified, but important knowledge gaps remain. The goal of the new global initiative described in this paper is to identify robust and reproducible brain signatures of measurable behaviors and clinical symptoms that are common in individuals with OCD.

View Article and Find Full Text PDF
Article Synopsis
  • There are proven ways to help people with obsessive-compulsive disorder (OCD), like medications that affect serotonin and cognitive behavior therapy (CBT).
  • Some people (25%-30%) don’t get better with these usual treatments, so doctors are looking for more options.
  • This review talks about how a part of the brain called the glutamatergic system might be different in people with OCD and examines new treatments using glutamatergic agents.
View Article and Find Full Text PDF

Objective: Baclofen is a promising treatment for alcohol use disorders (AUD), although its clinical response in humans is mixed. The present study aimed at investigating the impact of baclofen treatment on cue-induced brain activation pattern and its relationship with relapse outcomes.

Methods: Twenty-three inpatients with AUD underwent a functional magnetic resonance imaging cue-reactivity task before beginning medication with baclofen and 2 weeks later.

View Article and Find Full Text PDF

Background: It has been shown that mother infant interactions are often impaired in mothers with schizophrenia. Contributory factors include psychotic symptoms, negative symptoms and surrogate parenting by others.

Aim: This study describes the effectiveness of video feedback in enhancing mother-infant interaction in mothers with schizophrenia who have impaired interaction with their infant.

View Article and Find Full Text PDF